T1	Intervention 821 981	Defibrotide at a dose of 400 mg b.i.d. i.v. in 50 ml phleboclysis in 5 minutes (n = 108); 2) calcium heparin at a dose of 5000 IU t.i.d. subcutaneously (n = 103
T2	Intervention 984 1100	The treatment began the day before operation and continued on average up to the eighth day for the Defibrotide group
